GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
7Q3Q | 7Q3Q | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 | |
7Q3R | A0A6H2EIN2 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 | |
7Q3R | 7Q3R | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 | |
7Q3Y | P12821 | Structure of full-length, monomeric, soluble somatic angiotensin I-converting enzyme showing the N- and C-terminal ellipsoid domains | |
7Q49 | P12821 | Local refinement structure of the N-domain of full-length, monomeric, soluble somatic angiotensin I-converting enzyme | |
7Q4C | P12821 | Local refinement structure of the C-domain of full-length, monomeric, soluble somatic angiotensin I-converting enzyme | |
7Q4D | P12821 | Local refinement structure of the two interacting N-domains of full-length, dimeric, soluble somatic angiotensin I-converting enzyme | |
7Q4E | P12821 | Local refinement structure of a single N-domain of full-length, dimeric, soluble somatic angiotensin I-converting enzyme | |
7Q4I | Q7K237 | Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP | |
7Q4I | P15941 | Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP | |
7Q4T | F4YDQ3 | Structure of the Pseudomonas aeruginosa bacteriophage JG004 endolysin Pae87 bound to a peptidoglycan fragment. | |
7Q4T | 7Q4T | Structure of the Pseudomonas aeruginosa bacteriophage JG004 endolysin Pae87 bound to a peptidoglycan fragment. | |
7Q5C | P76045 | Crystal structure of OmpG in space group 96 | |
7Q5D | Q9UNN8 | Structure of EPCR in a non-canonical conformation | |
7Q61 | A8K2U0 | Structure of TEV conjugated A2ML1 (A2ML1-TC) | |
7Q62 | A8K2U0 | Structure of TEV cleaved A2ML1 dimer (A2ML1-TT dimer) | |
7Q6E | P0DTC2 | Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants | |
7Q6E | 7Q6E | Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants | |
7Q9F | P0DTC2 | Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9F | 7Q9F | Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9G | P0DTC2 | COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9G | 7Q9G | COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9I | P0DTC2 | Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9I | 7Q9I | Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9J | P0DTC2 | Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9J | 7Q9J | Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9K | P0DTC2 | Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9K | 7Q9K | Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9M | P0DTC2 | Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9M | 7Q9M | Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9P | P0DTC2 | Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7Q9P | 7Q9P | Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
7QA4 | Q91MA7 | Crystal structure of stabilized H3N2 A/Hong Kong/1/1968 Hemagglutinin at 2.2 Angstrom | |
7QA8 | P0CI39 | Structure of the GPCR dimer Ste2 bound to an antagonist | |
7QA8 | 7QA8 | Structure of the GPCR dimer Ste2 bound to an antagonist | |
7QAK | P21836 | Mus Musculus Acetylcholinesterase in complex with 7-[(4-{[benzyl(methyl)amino]methyl}benzyl)oxy]-4-(hydroxymethyl)-2H-chromen-2-one | |
7QB4 | P21836 | Mus Musculus Acetylcholinesterase in complex with 7-[(1-benzylpiperidin-3-yl)methoxy]-3,4-dimethyl-2H-chromen-2-one | |
7QB5 | V9VEF3 | Coxsackievirus A24v (CVA24v) in complex with a dimeric C2-C9-linked sialic acid inhibitor | |
7QB9 | P0CI39 | Structure of the ligand-free GPCR dimer Ste2 | |
7QBC | P0CI39 | Structure of the GPCR dimer Ste2 in the inactive-like state bound to agonist | |
7QBC | 7QBC | Structure of the GPCR dimer Ste2 in the inactive-like state bound to agonist | |
7QBI | P0CI39 | Structure of the GPCR dimer Ste2 in the active-like state bound to agonist | |
7QBI | 7QBI | Structure of the GPCR dimer Ste2 in the active-like state bound to agonist | |
7QBQ | P06276 | Human butyrylcholinesterase in complex with (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide | |
7QBR | P06276 | Human butyrylcholinesterase in complex with (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinolin-2-yl)methanimine oxide | |
7QCL | Q02817 | Structure of the MUCIN-2 Cterminal domains | |
7QCN | Q02817 | Structure of the MUCIN-2 Cterminal domains: vWCN to TIL domains with a C2 symmetry | |
7QCU | Q02817 | Structure of the MUCIN-2 Cterminal domains partially deglycosylated. | |
7QDG | P10104 | SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up | |
7QDG | P0DTC2 | SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024